Contents

Search


targeted alpha therapy

Indications: - radiation therapy for targeted treatment of cancer - radium-223 is a commercially available targeted alpha therapy for treatment of metastatic castration-resistant prostate cancer with bone metastases Mechanism of action: - high-energy emission of short-range alpha particles causes double-stranded DNA breaks, eliciting cell death - short-range emission of alpha particle radiation confines cytotoxic effect to targeted lesions & surrounding microenvironment - no known resistance mechanism to alpha particles

General

radiation therapy (XRT)

References

  1. Targeted Alpha Therapy Working Group Targeted Alpha Therapy, an Emerging Class of Cancer Agents. A Review. JAMA Oncol. Published online September 20, 2018 PMID: 30326033 https://jamanetwork.com/journals/jamaoncology/fullarticle/2703121